Jeannine Choppin

Title: Jeannine Choppin: Innovator in HPV Vaccine Development

Introduction

Jeannine Choppin is a notable inventor based in Rosny Sous Bois, France. She has made significant contributions to the field of medical research, particularly in the development of vaccines targeting Human Papillomavirus (HPV). With a total of 2 patents, her work focuses on innovative approaches to enhance immune responses against HPV.

Latest Patents

Choppin's latest patents include groundbreaking research on polyepitopic protein fragments of the E6 and E7 proteins of HPV. These patents detail the production and use of these fragments, particularly in vaccination strategies. One of her notable inventions involves polyepitopic peptides of the E6 and E7 proteins, which are designed to treat pathologies recognized by the cellular immune system. Additionally, her work on polyepitopic proteinic fragments emphasizes the importance of peptide sequences that bind stably to various HLA molecules, enhancing the efficacy of vaccines.

Career Highlights

Throughout her career, Jeannine Choppin has worked with esteemed organizations such as Peptide Immune Ligands and the Institut National de la Santé et de la Recherche Médicale. Her research has been pivotal in advancing the understanding of HPV and its associated health risks.

Collaborations

Choppin has collaborated with notable colleagues, including Francine Connan and Estelle Ferries, contributing to a rich exchange of ideas and expertise in her field.

Conclusion

Jeannine Choppin's innovative work in HPV vaccine development showcases her dedication to improving public health through scientific research. Her contributions continue to influence the landscape of medical advancements in immunology and vaccine technology.